The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
The system is powered by BrainSense technology, which has received approval from USFDA
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
Subscribe To Our Newsletter & Stay Updated
